» SCOLR Pharma, Inc. Submits Abbreviated New Drug Application For A 12-hour CDT-based Pseudoephedrine Formulation
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that 89 percent of surveyed rheumatologists anticipate prescribing…